Winfried Brenner Selected Research

DOTA(0)-Tyr(3)- 177Lu-octreotide

10/2021	Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATOC: A Pilot Study.
1/2021	Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Winfried Brenner Research Topics

Disease

22	Neoplasms (Cancer) 10/2021 - 06/2003
10	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 01/2016
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 07/2010
6	Neoplasm Metastasis (Metastasis) 02/2021 - 02/2012
4	Parkinsonian Disorders (Parkinsonism) 08/2017 - 07/2013
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2021 - 12/2008
3	Carcinoma (Carcinomatosis) 11/2014 - 12/2008
3	Meningioma (Meningiomas) 01/2013 - 02/2010
2	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2005
2	Hypoxia (Hypoxemia) 01/2019 - 08/2011
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2009
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2015 - 08/2015
2	Rheumatoid Arthritis 05/2005 - 06/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2004 - 04/2003
2	Myocardial Infarction 03/2004 - 04/2003
1	Thyroid Diseases (Thyroid Disease) 10/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Astrocytoma (Pilocytic Astrocytoma) 05/2021
1	Central Nervous System Neoplasms 05/2021
1	Ependymoma 05/2021
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 05/2021
1	Medulloblastoma 05/2021
1	Glioma (Gliomas) 05/2021
1	Disease Progression 05/2021
1	Lymphoma (Lymphomas) 08/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Tumor Lysis Syndrome 01/2019
1	Parkinson Disease (Parkinson's Disease) 08/2017
1	Lymphatic Metastasis 10/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Carcinoid Tumor (Carcinoid) 12/2015
1	Nervous System Diseases (Neurological Disorders) 10/2015

Drug/Important Bio-Agent (IBA)

9	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 06/2004
7	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 02/2010
7	Edotreotide (SMT 487)IBA 09/2020 - 02/2010
6	AntigensIBA 03/2021 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 10/2005
5	Radioisotopes (Radionuclides)IBA 06/2022 - 02/2014
5	Peptide Receptors (Peptide Receptor)IBA 06/2022 - 02/2014
5	Biomarkers (Surrogate Marker)IBA 02/2021 - 08/2015
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 01/2019
3	Peptides (Polypeptides)IBA 10/2021 - 01/2019
3	Ga(III)-DOTATOCIBA 01/2020 - 01/2012
3	EnzymesIBA 12/2019 - 08/2008
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 08/2017 - 10/2015
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2017 - 07/2013
2	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 10/2021 - 01/2021
2	Prostate-Specific Antigen (Semenogelase)IBA 03/2021 - 01/2021
2	RadiopharmaceuticalsIBA 01/2021 - 02/2020
2	gallium 68 PSMA-11IBA 06/2019 - 01/2018
2	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 12/2017 - 01/2016
2	alovudineIBA 09/2008 - 08/2008
2	salicylhydroxamic acid (SHAM)IBA 03/2004 - 04/2003
1	gadobutrolIBA 10/2022
1	FluoridesIBA 10/2022
1	A-factor (Streptomyces)IBA 10/2021
1	gonadotropin releasing hormone associated peptideIBA 05/2021
1	Proteasome InhibitorsIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	177Lu-DOTA-JR11IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 08/2020
1	68Ga-pentixaforIBA 02/2020
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2019
1	Histone Deacetylase InhibitorsIBA 12/2019
1	PlatinumIBA 12/2019
1	animacroxamIBA 12/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	CateninsIBA 01/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	ChemokinesIBA 01/2019
1	acetyl0Nle(4)-Asp(5)-Phe(7)- alpha-MSH (4-11)IBA 01/2019
1	GalliumIBA 12/2017
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 12/2017
1	Complement System Proteins (Complement)IBA 12/2017
1	AcidsIBA 12/2017
1	PSMA-617IBA 01/2017
1	177Lu-PSMA-617IBA 01/2017
1	Alkaline PhosphataseIBA 01/2017
1	Biological ProductsIBA 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 10/2015

Therapy/Procedure

22	Therapeutics 10/2022 - 04/2003
5	Radiotherapy 01/2022 - 02/2010
5	Drug Therapy (Chemotherapy) 02/2009 - 04/2003
3	Castration 03/2021 - 01/2017
2	Precision Medicine 09/2021 - 01/2019
2	Investigational Therapies (Experimental Therapy) 08/2020 - 02/2015
2	Transplantation 03/2004 - 04/2003
1	Operative Surgical Procedures 05/2021
1	Combined Modality Therapy 05/2021
1	Intravenous Injections 01/2021
1	Homologous Transplantation 08/2020